Derm-Biome Pharmaceuticals adds Dr. Jerry Tan, internationally renowned expert in acne and acne scarring, to its Scientific Advisory Board
November 25, 2024 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver-based biopharmaceutical company developing safe and highly effective topical treatments...
Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’
May 23, 2024 07:00 ET
|
Tilray Brands, Inc.
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- May 23, 2024 – Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company today announces the latest...
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
April 17, 2024 10:15 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most...
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
April 16, 2024 08:00 ET
|
Right On Brands, Inc.
OTC:RTON will begin marketing the super premium products of HONEY® Brands throughout its growing network of retailers.
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
April 10, 2024 08:15 ET
|
Right On Brands, Inc.
DALLAS, April 10, 2024 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON) ("RTON" or the "Company"), a fully reporting SEC company and a leading developer of a diverse range of hemp-based...
Right On Brands, Inc. Continues Impressive Rollout, Announces 12th Store Opening
March 14, 2024 08:00 ET
|
Right On Brands, Inc.
Right on Brands, Inc. (OTC PINK: RTON) is opening its 12th licensed store in the fastest growing county in the country.
Derm-Biome Pharmaceuticals prepares to begin IND-enabling studies for DB-007-4, a potential best-in-class treatment for inflammatory skin diseases
February 27, 2024 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company developing novel topical therapies for inflammatory skin...
Topical Antibiotics Market Size Projected to Reach USD 10.0 billion by 2031, With 5.1% CAGR: Transparency Market Research, Inc.
February 21, 2024 00:40 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global topical antibiotics market is estimated to flourish at a CAGR of 5.1% from 2023...
Hemostasis Products Market revenue to hit USD 1.73 Billion by 2033, says Research Nester
February 06, 2024 07:30 ET
|
Research Nester
New York, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The global hemostasis products market size is estimated to attain at ~5.1% CAGR from 2023 to 2033. The market is expected to garner a revenue of USD 1.73...
Compounding Pharmacies Market revenue to exceed USD 27 Billion by 2035, says Research Nester
January 22, 2024 05:30 ET
|
Research Nester
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global compounding pharmacies market size is slated to expand at ~9% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 27...